← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2016Last known activity
Feb 1, 2023
Timeline
2010s
- Apr 1, 2016
The Parker Institute— Founded
Drugs by trial phase (23 distinct, 13 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Coronavirus Infections
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Melanoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Osteoarthritis
- Osteoarthritis, Knee
- Prostatic Neoplasms
- Virus Diseases
- Weight Loss
Recent trials (23)
- NCT05478837CollaboratorPhase 1Feb 1, 2023
- NCT04787991Lead sponsorPhase 1Aug 9, 2021
- NCT04787991OfficialPhase 1Aug 9, 2021
- NCT04787991Study directorPhase 1Aug 9, 2021
- NCT04784247CollaboratorPhase 2Mar 18, 2021
- NCT04322773Overall official - principal investigatorPhase 2Apr 5, 2020
- NCT04007029CollaboratorPhase 1Aug 1, 2019
- NCT03835533OfficialPhase 1Jun 30, 2019
- NCT03835533Lead sponsorPhase 1Jun 30, 2019
- NCT03835533Study directorPhase 1Jun 30, 2019
- NCT03817125Study directorPhase 1Jan 28, 2019
- NCT03817125Lead sponsorPhase 1Jan 28, 2019
- NCT03651271OfficialPhase 2Sep 14, 2018
- NCT03651271Study directorPhase 2Sep 14, 2018
- NCT03651271Lead sponsorPhase 2Sep 14, 2018
Details
- Founded
- San Francisco, CA, US Apr 1, 2016
- Last known activity
- Feb 1, 2023